相关实验视频
Updated: Jan 10, 2026

05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
877
肠道微生物组和肥胖症:一个多维叙事审查
Bidisha Barat1, Kinanka Ghosh2, Bipin Kulkarni3
1The University of Chicago, Chicago, IL, 60637, USA.
Microbial genomics
|November 27, 2025
概括
肠道微生物群通过影响营养吸收,食欲调节和炎症,显著影响肥胖. 针对肠道微生物组为这种全球性流行病提供了有希望的治疗策略.
科学领域:
- 微生物学 微生物学
- 代谢健康 代谢健康
- 胃肠病学 胃肠病学
背景情况:
- 肥胖是一种全球性流行病,影响全球20%的成年人.
- 改变的肠道微生物组是肥胖的一个重要发现.
- 肠道微生物组在宿主新陈代谢和生理学中起着至关重要的作用.
研究的目的:
- 审查改变肠道微生物组导致肥胖的机制.
- 探索肠道微生物在营养吸收,食欲调节和内分泌功能中的作用.
- 确定针对肠道微生物组的潜在治疗策略,用于肥胖管理.
主要方法:
- 对调查肠道微生物组和肥胖的研究进行文献综述.
- 对将肠道微生物组变化与肥胖病原发生联系起来的机制的分析.
- 对肥胖的新兴治疗方法的评估.
主要成果:
- 肠道微生物组影响营养吸收,饮食成分的加工和能量收获.
- 微生物组的改变会影响肠道生理学,内分泌功能和免疫反应.
- 肠道微生物组与中枢神经系统通信,影响食欲和腹感.
- 机制包括免疫调节,慢性炎症,表观遗传调节和维生素生产.
结论:
- 肠道微生物组是肥胖发展和进展的关键因素.
- 准肠道微生物组为肥胖提供了有希望的治疗途径.
- 策略包括工程有益细菌,益生菌和专门的饮食.
相关概念视频
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
161
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
161
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
225
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
225
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
617
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
617
Assessment of the Gastrointestinal System II: Health Perception Pattern
434
Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
434
Chronic Bowel Disorders: Introduction
734
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
734

